Peter Vozzo | Investor Relations |
Jack Khattar | Chief Executive Officer |
Greg Patrick | Chief Financial Officer |
Ken Cacciatore | Cowen & Company |
David Steinberg | Jefferies |
Annabel Samimy | Stifel |
Patrick Trucchio | Berenberg Capital |
Irina Koffler | Mizuho |
David Amsellem | Piper Jaffray |
David Buck | B. Riley FBR |
Esther Hong | Janney |
Good morning, ladies and gentlemen and welcome to the Supernus Pharmaceuticals Fourth Quarter and Full Year 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Instructions will follow at that time.
As a reminder, this conference call is being recorded.